Merck Raises 2023 Sales Forecast as Cancer Drug Keytruda, Gardasil Vaccine Surge
Merck & Co.’s Keytruda and Gardasil soundly beat analysts’ estimates for quarterly sales, driving the company’s annual revenue
2023-08-01 18:56
CVS to Cut About 5,000 Jobs in Cost-Reduction Push, WSJ Reports
CVS Health Corp. said it would cut about 5,000 jobs to help reduce costs, with most of the
2023-08-01 11:29
Amazon, Apple Earnings to Provide Look at Consumer Habits
Consumer habits will come to the fore again in this week’s earnings deluge, as Amazon.com Inc., Shopify Inc.
2023-07-31 18:47
Secret Deals With Russia Help Kim Jong Un Fund Nuclear Program
Reports of new types of sugar in the local markets. Satellite imagery of trains crossing borders. Cargo ships
2023-07-31 11:46
Biogen to Buy Reata for $7.3 Billion in Rare-Disease Expansion
Biogen Inc. agreed to acquire Reata Pharmaceuticals Inc. for $7.3 billion including debt to expand its rare disease
2023-07-28 19:49
Global Bonds Fall as Japan Tweaks Yield Control: Markets Wrap
Bonds around the world retreated after the Bank of Japan, so far a holdout on ultra-loose monetary policy,
2023-07-28 16:15
Astra Strikes $1 Billion Gene Therapy Deal With Pfizer
AstraZeneca Plc has agreed to buy a portfolio of rare disease gene therapies from Pfizer Inc. as the
2023-07-28 15:24
Sanofi Lifts Guidance on Dupixent, Covid Vaccine Sales
Sanofi raised its forecast for the year as the French drugmaker gains new patients for blockbuster drug Dupixent
2023-07-28 13:51
North Korea Economy Shrinks Again as Pandemic Impact Drags On
North Korea’s economy shrank for a third year as the pandemic continued to weigh on activity, but resurgent
2023-07-28 11:23
GSK Raises Outlook, Looks to New Medicines to Fuel Growth
GSK Plc raised its guidance for the year after a strong start to 2023 as it prepares to
2023-07-26 15:15
The Little Known Metals Giant that Rules a Global Market
When China’s Vital Materials Co. bought up a $600 million stockpile of obscure critical minerals in early 2020,
2023-07-25 12:29
Bayer Cuts 2023 Outlook Amid Slump in Prices for Roundup
Bayer AG cut its outlook for the year amid persistently low prices for agriculture products, including the controversial
2023-07-25 02:17